Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Am J Kidney Dis. 2014 Oct 23;65(4):550–558. doi: 10.1053/j.ajkd.2014.08.021

Table 3.

Model performance measures with the addition of continuous hs-cTnT or NT-proBNP to Model 4 variables.

C-statistic NRI, categorical** NRI, continuous IDI
Model 4 0.884 (0.858 to 0.909)
hs-cTnT 0.892 (0.869 to 0.916) 0.001 (−0.037 to 0.040) 0.195 (0.067 to 0.322) 0.010 (0.003 to 0.018)
NT-proBNP 0.888 (0.864 to 0.913) 0.005 (−0.024 to 0.034) 0.148 (0.020 to 0.276) 0.004 (−0.001 to 0.009)
hs-cTnT and NT-proBNP 0.894 (0.871 to 0.917) 0.005 (−0.036 to 0.046) 0.176 (0.048 to 0.303) 0.012 (0.003 to 0.020)
*

P<0.001

P<0.01

P<0.05

**

10-year risks of 10% and 30% were used as thresholds for categorical NRI.

Note: Data are given as value (95% confidence interval). All prediction statistics were based on 10-year predicted risk. Model 4 variables included: age, gender, race, systolic blood pressure, antihypertensive medication, smoking, alcohol intake, level of education, body mass index, total and high-density lipoprotein cholesterols, diabetes, history of cardiovascular disease, estimated glomerular filtration rate and albuminuria (albumin-creatinine ratio) at baseline

Abbreviations: hs-cTnT, high-sensitivity cardiac troponin T; NT-proBNP, N-terminal pro–brain natriuretic peptide; net reclassification improvement (NRI), integrated discrimination improvement (IDI)